KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) EBITDA (2016 - 2025)

Historic EBITDA for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to -$89000.0.

  • Biolife Solutions' EBITDA rose 7870.81% to -$89000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.1 million, marking a year-over-year decrease of 41963.03%. This contributed to the annual value of -$7.1 million for FY2024, which is 6958.62% up from last year.
  • Latest data reveals that Biolife Solutions reported EBITDA of -$89000.0 as of Q3 2025, which was up 7870.81% from -$16.6 million recorded in Q2 2025.
  • Biolife Solutions' EBITDA's 5-year high stood at $90.3 million during Q4 2022, with a 5-year trough of -$76.6 million in Q2 2022.
  • Its 5-year average for EBITDA is -$5.0 million, with a median of -$4.6 million in 2021.
  • Its EBITDA has fluctuated over the past 5 years, first plummeted by 1045227.27% in 2021, then soared by 58928.78% in 2022.
  • Over the past 5 years, Biolife Solutions' EBITDA (Quarter) stood at -$18.5 million in 2021, then skyrocketed by 589.29% to $90.3 million in 2022, then plummeted by 87.5% to $11.3 million in 2023, then tumbled by 118.68% to -$2.1 million in 2024, then surged by 95.78% to -$89000.0 in 2025.
  • Its last three reported values are -$89000.0 in Q3 2025, -$16.6 million for Q2 2025, and -$1.2 million during Q1 2025.